References
- OatesAJacksonPRAustinCAChannerKSA new regimen for starting warfarin therapy in out-patientsBr J Clin Pharmacol19984621571619723825
- TaitRCSefcickAA warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillationBr J Haematol199810134504549633885
- FusterVRydénLEAsingerRWAmerican College of CardiologyAmerican Heart AssociationEuropean Society of CardiologyNorth American Society of Pacing and ElectrophysiologyACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and ElectrophysiologyEur Heart J200122201852192311601835
- GuyattGHAklEACrowtherMGuttermanDDSchuünemannHJAmerican College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis. 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141Suppl 27S47S22315257
- HirshJDalenJEDeykinDPollerLBusseyHOral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic rangeChest1995108Suppl 4231S246S7555179
- KeelingDBaglinTTaitCBritish Committee for Standards in HaemotologyGuidelines on oral anticoagulation with warfarin – fourth editionBr J Haematol2011154331132421671894
- ChanYCValentiDMansfieldAOStansbyGWarfarin induced skin necrosisBr J Surg200087326627210718793
- NgTTillyerMLWarfarin-induced skin necrosis associated with Factor V Leiden and protein S deficiencyClin Lab Haematol200123426126411683790
- NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508